Table 2 Characteristics among chart review sample and diabetes mellitus sample by adenomatous polyps
Variables | Adenomatous polyp among chart review sample | |||
Total N (%) | No (N = 1261) N (%) | Yes (N = 537) N (%) | P value | |
Age, years, mean (SD) | 56.20 (9.09) | 55.39 (9.12) | 58.09 (8.75) | < 0.0001 |
≤ 50 | 290 (16.1) | 233 (80.3) | 57 (19.7) | |
51~ 55 | 628 (34.9) | 441 (70.2) | 187 (29.8) | |
56~ 60 | 509 (28.3) | 347 (68.2) | 162 (31.8) | |
> 60 | 371 (20.6) | 233 (62.8) | 138 (37.2) | |
Gender | ||||
Female | 964 (53.6) | 712 (73.9) | 252 (26.1) | < 0.0001 |
Male | 834 (46.4) | 549 (65.8) | 285 (34.2) | |
Ethnicity | ||||
Caucasian | 874 (48.6) | 624 (71.4) | 250 (28.6) | 0.131 |
African American | 528 (29.4) | 380 (72.0) | 148 (28.0) | |
Hispanic | 342 (19.0) | 220 (64.3) | 122 (35.7) | |
Asian | 35 (1.9) | 24 (68.6) | 11 (31.4) | |
Other/unknown | 19 (1.1) | 13 (68.4) | 6 (31.6) | |
Body mass index, kg/m2, mean (SD) | 31.05 (7.06) | 30.70 (7.04) | 31.83 (7.03) | 0.004 |
< 18.5 | 6 (0.3) | 6 (100.0) | 0 (0.0) | 0.013 |
18.5–24.9 | 255 (14.2) | 196 (76.9) | 59 (23.1) | |
25–29.9 | 529 (29.4) | 369 (69.8) | 160 (30.2) | |
30–39.9 | 855 (47.6) | 405 (67.3) | 197 (32.7) | |
> 40 | 153 (8.5) | 98 (64.1) | 55 (35.9) | |
Diabetes | ||||
No | 1353 (75.3) | 976 (72.1) | 377 (27.9) | 0.001 |
Yes | 445 (24.7) | 285 (64.0) | 160 (36.0) | |
Adenomatous polyp among patient with Diabetes Mellitus (N = 445) | ||||
Age, years, mean (SD) | 58.76 (9.72) | 57.54 (9.34) | 60.91 (10.03) | 0.001 |
≤ 50 | 45 (10.1) | 35 (77.8) | 10 (22.2) | |
51~ 55 | 133 (29.9) | 89 (66.9) | 44 (33.1) | |
56~ 60 | 128 (28.8) | 82 (64.1) | 46 (35.9) | |
> 60 | 139 (31.2) | 78 (56.1) | 61 (43.9) | |
Gender | ||||
Female | 225(50.6) | 155(68.9) | 70(31.1) | 0.024 |
Male | 220(49.4) | 129(58.6) | 91(41.4) | |
Ethnicity | ||||
Caucasian | 169 (38.0) | 107 (63.3) | 62 (36.7) | 0.622 |
African American | 177 (39.8) | 119 (67.2) | 58 (32.8) | |
Hispanic | 80 (18.0) | 46 (57.5) | 34 (42.5) | |
Asian | 12 (2.7) | 7 (58.3) | 5 (41.7) | |
Other/unknown | 7 (1.6) | 5 (71.4) | 2 (28.6) | |
Body mass index, kg/m2, mean (SD) | 34.24 (7.54) | 34.28 (7.47) | 34.18 (7.67) | 0.903 |
< 18.5 | 2 (0.4) | 1 (50.0) | 1 (50.0) | |
18.5–24.9 | 26 (5.8) | 15 (57.7) | 11 (42.3) | |
25–29.9 | 90 (20.2) | 54 (60.0) | 36 (40.0) | |
30–39.9 | 205 (46.1) | 135 (65.9) | 70 (34.1) | |
> 40 | 71 (16.0) | 43 (60.6) | 28 (39.4) | |
Hemoglobin A1c | ||||
< 5.7 | 15 (3.4) | 10 (66.7) | 5 (33.3) | 0.903 |
5.7–6.4 | 126 (28.3) | 78 (61.9) | 48 (38.1) | |
6.5–7.9 | 214 (48.1) | 140 (65.4) | 74 (34.6) | |
≥ 8.0 | 71 (16.0) | 47 (66.2) | 24 (33.8) | |
Missing cases | 19 (4.3) | |||
Oral medication exposure | ||||
None | 204 (45.8) | 130 (63.7) | 74 (36.3) | 0.916 |
< 2 years | 105 (23.6) | 69 (65.7) | 36 (34.3) | |
≥ 2 years | 136 (30.6) | 86 (63.2) | 50 (36.8) | |
Insulin exposure | ||||
None | 371 (83.4) | 237 (63.9) | 134 (36.1) | 0.963 |
< 2 years | 24 (5.4) | 16 (66.7) | 8 (33.3) | |
≥ 2 years | 50 (11.20 | 32 (64.0) | 18 (36.0) | |